Beyond ICER: Arnold Foundation Wants To Dig Deeper On R&D And Pricing

Arnold Foundation VP Mark Miller explains how research into “what it costs to bring a drug to market” could supplement existing efforts to determine how prescription drug prices line up with value.

Spade in the ground - Image
The foundation behind ICER feels More Spadework On R&D Costs By Independent Third Parties Is Needed

More from Market Access

More from Pink Sheet